In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price ...

A. Baur & Co. Ltd., widely known as Baurs, a leading conglomerate with diversified business interests in Sri Lanka and a ...

Their appointment was initiated by the outgoing board of directors. The four new members will bring many years of experience in the biotech and ...

Data shows Norway, which is similar in population size to NZ, increased its five-year survival rates for ovarian cancer from 34.1% to 46.1% in the almost two decades from 1995. In contrast, New ...

Nijmegen, Netherlands Wednesday, April 23, 2025, 13:00 Hrs [IST] ...

Aldeyra Therapeutics, Inc. (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced the ...

When the success of medicine itself is directly ... witnessed large-scale pharma initiatives for social impact, such as GlaxoSmithKline’s £1 billion R&D initiative developing vaccines in ...

GlaxoSmithKline has found a replacement for ... His time at Pfizer has coincided with the spectacular success of its BioNTech-partnered mRNA vaccine for COVID-19 – Comirnaty – and as GSK ...

Learn more about whether Amicus Therapeutics, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor grades ...

In a world that often demands women to dim their light to fit in, Ms. Samantha Wuta-Ofei, well known as LadySam, has chosen ...

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately ...